Anaphylaxis

• 

  Subject Areas on Research

  • A comparison of adverse reaction rates for PAS C versus plasma platelet units. 
  • A retrospective study of complications of therapeutic plasma exchange in myasthenia. 
  • Adverse reactions to protamine. 
  • Allergic reactions during anesthesia. 
  • Allergic response to medical products in patients with alpha-gal syndrome. 
  • Alpha-Gal: A Delayed Onset of Anaphylaxis and Uncovering the Cause. 
  • Altered inflammatory responses in leukotriene-deficient mice. 
  • An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. 
  • Anaphylactic and anaphylactoid reactions. A review. 
  • Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. 
  • Anaphylactic reactions during anesthesia. 
  • Anaphylactic reactions in cardiac surgical patients: Et tu, Brute? 
  • Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis? 
  • Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. 
  • Anaphylactic reactions. 
  • Anaphylactic/anaphylactoid reactions during cardiac surgery. 
  • Anaphylactoid reaction due to the administration of ondansetron in a pediatric neurosurgical patient. 
  • Anaphylaxis after administration of gamma globulin for hypogammaglobulinemia. 
  • Anaphylaxis and coronary disease. 
  • Anaphylaxis during anesthesia. 
  • Anaphylaxis during cardiac surgery: implications for clinicians. 
  • Anaphylaxis following intravenous fluorescein angiography in a vitreoretinal clinic: report of 4 cases. 
  • Anaphylaxis to chymopapain after antihistamine pretreatment. 
  • Anaphylaxis to meperidine. 
  • Anaphylaxis. What is monitored to make a diagnosis? How is therapy monitored? 
  • Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use. 
  • Bee and wasp stings: reactions and anaphylaxis. 
  • Biomarkers in the diagnosis of anaphylaxis: making nature disclose her mysteries. 
  • Case 4-2007. Aprotinin-induced cardiovascular collapse after a negative test dose in a patient scheduled for repeat mitral valve surgery. 
  • Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. 
  • Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. 
  • Diagnosis and treatment of anaphylactic/anaphylactoid reactions. 
  • Diagnosis of Life-Threatening Alpha-Gal Food Allergy Appears to Be Patient Driven. 
  • Diagnosis of phacoanaphylactic endophthalmitis by fine needle aspiration biopsy. 
  • Efficacy and safety of aprotinin in cardiac surgery. 
  • Enhancing pediatric safety: using simulation to assess radiology resident preparedness for anaphylaxis from intravenous contrast media. 
  • Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. 
  • Evaluation of patients at risk for protamine reactions. 
  • IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. 
  • Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. 
  • In Vitro and In Vivo IgE-/Antigen-Mediated Mast Cell Activation. 
  • Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. 
  • Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines. 
  • Intraosseous infusion in an emergency situation: a case report. 
  • Intravenous epinephrine therapy in anaphylaxis. 
  • Laboratory Animal Bite Anaphylaxis: A National Survey: Part 1: Case Series and Review of the Literature. 
  • Laboratory Animal Bite Anaphylaxis: A National Survey: Part 2: Treatment Protocols. 
  • Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. 
  • Mast cell desensitization inhibits calcium flux and aberrantly remodels actin. 
  • Negative control of mast cell degranulation and the anaphylactic response by the phosphatase lipin1. 
  • New concepts in the treatment of anaphylactoid reactions in anesthesia. 
  • Perioperative Anaphylaxis. 
  • Perioperative anaphylaxis and the United States perspective. 
  • Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles. 
  • Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. 
  • Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002). 
  • Postoperative ST-segment elevation: was vasospasm caused by anaphylaxis or by its treatment with epinephrine? 
  • Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy. 
  • Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. 
  • Protamine and its cardiovascular effects. 
  • Protamine, is something fishy about it? The spectre of anaphylaxis continues. 
  • Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. 
  • Safety of aprotinin in heparinized and nonheparinized patients. 
  • Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy. 
  • Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. 
  • Steroid premedication before i.v. contrast-enhanced CT resulting in resolution of lymphadenopathy. 
  • Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. 
  • Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers. 
  • Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. 
  • Suspected protamine allergy: diagnosis and management for coronary artery surgery. 
  • Symposium on the definition and management of anaphylaxis: summary report. 
  • Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 
  • The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. 
  • The radiology perspective: needs and tools for management of life-threatening events. 
  • Treatment of adverse reactions to radiographic contrast media in adults. 
  • Treatment of reactions to radiographic contrast material. 
  • Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. 
  • Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab. 
• 

  Keywords of People

  • Levy, Jerrold Henry, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Zhong, Xiaoping, Professor of Pediatrics, Immunology